SCHEMBL13862191

SCHEMBL13862191

CN(C)c1cc(Cc2cccc(I)c2F)cc2c(=O)c(C=O)cn(CCO)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13862190 0.90 CFD (0.35) —
SCHEMBL11956950 0.86 ALDH1A1 (0.30) —
SCHEMBL11956943 0.85 — —
SCHEMBL13862195 0.79 ALDH1A1 (0.31) —
SCHEMBL11956951 0.78 METTL3 (0.34) —
SCHEMBL14611459 0.77 KDM4E (0.38) —
SCHEMBL12957421 0.76 ALDH1A1 (0.35) —
SCHEMBL13862214 0.76 ALDH1A1 (0.37) —
SCHEMBL1045267 0.75 METTL3 (0.44) —
SCHEMBL13862197 0.74 ALDH1A1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531554-B2 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid JAPAN TOBACCO INC. (JP) 2009-05-12 — — US disclosed
Send feedback